Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01609816
Title Dasatinib in Treating Patients With Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Previously Treated With Autologous Stem Cell Transplant
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

Hodgkin's lymphoma

multiple myeloma

non-Hodgkin lymphoma

Therapies

Dasatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.